Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01940276 · ClinicalTrials.gov registry record · Phase 2
Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT01940276 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 100 participants.
The verdict
NCT01940276, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
The primary goal is to prospectively estimate the median radiographic PFS of African American and Caucasian men with mCRPC to abiraterone acetate and prednisone.
Interventions
- DRUG Prednisone
- DRUG Abiraterone acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2013-10 |
| Est. Completion | 2019-10-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01940276
The ClinicalTrials.gov registry entry for NCT01940276 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prednisone is the first listed.
NCT01940276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01940276 about?
NCT01940276 is a clinical study titled "Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer". The primary goal is to prospectively estimate the median radiographic PFS of African American and Caucasian men with mCRPC to abiraterone acetate and prednisone.
What is the current status of trial NCT01940276?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2013-10. Estimated completion is 2019-10-08.
What interventions are being tested in trial NCT01940276?
The interventions under investigation include: Prednisone (DRUG), Abiraterone acetate (DRUG).
Who is sponsoring clinical trial NCT01940276?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.